Amman, Jordan

Multidisciplinary management of head and neck oncology

This multidisciplinary course is aimed at specialists and trainees with an interest and expertise in head and neck surgery (head and neck surgeons, oto-rhino-laryngologists, maxillo-facial surgeons, reconstructive surgeons, etc.), radiation oncologists, medical oncologists and other medical specialists involved in the treatment of patients with head and neck cancer.


  • Vincent Grégoire, Radiation Oncologist, Centre Léon Bérard Lyon  
  • René Leemans, ORL/Head and Neck Surgeon, Amsterdam University Medical Centres, VU University, Amsterdam (NL) 
  • Lisa Licitra, Medical Oncologist, Istituto Tumori, Milan and University of Milan (IT)


  • Jesper Grau Eriksen, Clinical Oncologist, Arhus University Hospital (DK)
  • Jean-Pascal Machiels, Medical Oncologist, Cliniques Universitaires St-Luc, Brussels (BE)
  • Piero Nicolai, Oto-Rhino-Laryngologist and Head and Neck Surgeon, University of Brescia, Brescia (IT)
  • Frank A. Pameijer, Radiologist, University Medical Center Utrecht (UMCU), The Netherlands





The course aims to be interactive through integration of multidisciplinary lectures and more focused workshops. The faculty includes renowned European experts involved in the multidisciplinary treatment of head and neck cancer.


By the end of this course participants should be able to:

  • Understand the evolving concepts of head and neck epidemiology and tumour biology, with special focus on squamous cell histotype. Rare histotypes will also be included
  • Interpret complex head and neck imaging for the purpose of treatment decision making and therapy
  • Make judgements regarding multidisciplinary reasoning and management of tumours in the light of alternative and sometimes competing treatment options, including surgery and the role of systemic and targeted therapies 
  • Make judgments on the availability of evidence for treatment recommendations
  • Understand the challenges of supportive care 
  • Understand the principles and practice of modern radiotherapy


  • Anatomy (clinical and radiologic aspects) incidence, pathology, risk factors (including HPV) of head and neck tumours 
  • Clinical work-up for oral cavity and pharyngo-laryngeal tumours, staging and follow up 
  • "Organ preservation” approach
  • Rationale for unconventional radiotherapy fractionation, hypoxic sensitisers, concomitant chemo, EGFR inhibitors, immunotherapy and new targeted agents
  • Management of oral cavity tumours: medical oncology, surgery and radiotherapy (including brachytherapy)
  • Management of nasopharyngeal carcinoma
  • Management of oropharyngeal tumours: medical oncology, surgery and radiotherapy (including brachytherapy)
  • Management of hypopharyngeal and laryngeal tumours: surgery, radiotherapy and medical oncology chemotherapy approach
  • Management of nasal cavity and para-nasal sinus tumours: surgery, radiotherapy and medical oncology chemotherapy approach
  • Management of salivary gland tumours: surgery, radiotherapy and medical oncology chemotherapy approach
  • Management of the neck nodes
  • Concepts behind selection and delineation of target volumes in radiotherapy 
  • Morbidity (acute and late) of treatment
  • Supportive care during and after treatment
  • Metastatic disease
  • Management of recurrent tumours 
  • Second primary tumours




Before commencing this course, participants should have a medical degree with strong interest in head and neck tumour management from the radiation oncology, medical oncology or head and neck surgery point of view.



  • 20 lecture hours
  • 5 case discussion hours
  • Delineation exercises


  • MCQ 
  • Delineation exercise/s 
  • Evaluation form.



Programme to follow


  • Multidisciplinary head and neck oncology
  • Evidence based medicine


To be provided if available


Application for CME recognition will be submitted to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA). Information on the status of the applications can be obtained from the ESTRO office.

To follow


ESTRO members can order products at substantially reduced prices. To benefit from the member registration rate, you must subscribe for the ESTRO membership 2023 BEFORE registering to the course. To become an ESTRO member, benefit from the member registration rate and discover the many other member advantages, please visit the membership page.



Early rate

Late rate


  750 EUR

 850 EUR

ESTRO Members

  600 EUR 

 725 EUR

In-training members*

  450 EUR

 625 EUR

* Members with specialty RadiationTherapist (RTT) may register at the In-Training fee

Early rates are applied up to 2 months before the starting date of the course.

Late rates are applied 2 months before the starting date of the course.

The fee includes the course material, coffees, lunches, and the social event.

Advance registration & payment are required.

Since the number of participants is limited, late registrants are advised to contact the ESTRO office before payment, to inquire about availability of places. Access to homework and/or course material will become available upon receipt of full payment.

Insurance and cancellation

The organiser does not accept liability for individual medical, travel or personal insurance. Participants are strongly advised to take out their own personal insurance policies.   

In case an unforeseen event would force ESTRO to cancel the meeting, the Society will reimburse the participants fully the registration fees. ESTRO will not be responsible for the refund of travel and accommodation costs.

In case of cancellation, full refund of the registration fee minus 15% for administrative costs may be obtained up to two months before the course and 50% of the fee up to one month before the course. No refund will be made if the cancellation request is postmarked less than one month before the start of the course.

Reduced fees

Members from emerging countries may register at a preferential rate of 350 Euro. Emerging country fee applies to individuals from low-income and lower-middle-income economies according to the World Bank listing here.

Additionally, all specialties from the following countries can benefit from this preferential rate: Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Greece, Hungary, Latvia, Lithuania, Macedonia, Moldova, Montenegro, Poland, Portugal, Romania, Russian Federation, Serbia, Slovak Republic, Slovenia, Spain, Turkey, Ukraine.  In addition, medical physicists from Cyprus can email to apply for this fee.

The preferential rate of 350 Euro is granted automatically when you click on the  BOOK NOW  button and the three conditions below are met:

  1. Only ESTRO members for 2023 are eligible (please make sure your 2023 membership is in order before you click on the BOOK NOW  button)
  2. Only one course per person per year can be subsidized by ESTRO
  3. Sponsored candidates are not entitled to reduced fees (the invoicing address has to be the one of the participant)  

 Please note:

  • We can only guarantee a certain number of reduced fees per course
  • Application deadlines are the same as early registration fees